Vascular Dementia

REFERENCES

• Gorelick PB, Roman G, Mangone CA. Vascular dementia. In: Gorelick PB, Alter M, eds. Handbook of Neuroepidemiology. New York: Marcel Dekker; 1994:197–208.
   Google Scholar
• Roman GC. Vascular dementia revisited: diagnosis, pathogenesis, treatment, and prevention. Med Clin North Am. 2002;86:477–499.
   PubMed Web of Science ®Google Scholar
• Hachinski VC, Iliff LD, Zilhka E, et al. Cerebral blood flow in dementia. Arch Neurol. 1975;32(9):632–637.
   PubMed Web of Science ®Google Scholar
• O’Neill D, Gerrrard J, Surmon D, Wilcock GK. Variability in scoring the Hachinski Ischaemic Score. Age Ageing. 1995;24(3):242–246.
   PubMed Web of Science ®Google Scholar
• Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43(2):250–260.
   PubMed Web of Science ®Google Scholar
• Black SE. Vascular dementia: stroke risk and sequelae define therapeutic approaches. Postgrad Med. 2005;117(1):15–25.
   PubMed Web of Science ®Google Scholar
• Knopman DS, DeKosky ST, Cummings JL, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56(9):1 143-1153.
   Google Scholar
• Pohjasvaara T, Mantyla R, Ylikoski R, et al. Comparison of different clinical criteria (DSM-III, AdDtC, ICD-10, NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia. Stroke. 2000;31 (1 2):2952–2957.
   Google Scholar
• Vermeer SE, Prins ND, den Heijer T, et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348(13):1215–1222.
   PubMed Web of Science ®Google Scholar
• Farlow MR. Use of antidementia agents in vascular dementia: beyond Alzheimer disease. Mayo Clin Proc. 2006;81(10):1350–1358.
   PubMed Web of Science ®Google Scholar
• Leysa D, Pasquier F, Parnetti L. Epidemiology of vascular dementia. Haemostasis. 1998;28:134–150.
   PubMedGoogle Scholar
• Roman GC. Vascular dementia may be the most common form of dementia in the elderly. J Neurol Sci. 2002;203–204:7–10.
   Google Scholar
• Wolfson C, Wolfson DB, Asgharian M, et al. Clinical Progression of Dementia Study Group. A reevaluation of the duration of survival after the onset of dementia. N Engl J Med. 2001;344(15):1111–1116.
   PubMed Web of Science ®Google Scholar
• Joutel A, Corpechot C, Ducros A, et al. Notch 3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 1996;383:707–710.
   PubMed Web of Science ®Google Scholar
• in’t Veld BA, Ruitenberg A, Hofman A, Stricker BH, Breteler MM. Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiol Aging. 2001;22(3):407–412.
   PubMed Web of Science ®Google Scholar
• Freels S, Nyenhuis DL, Gorelick PB. Predictors of survival in African American patients with AD, VaD, or stroke without dementia. Neurology. 2002; 59:1 146–1 153.
   Google Scholar
• Schneck MJ. “Silent” strokes and dementia. New Engl J Med. 2003;349(1):96.
   PubMed Web of Science ®Google Scholar
• Williams PS, Spector A, Orrell M, Rands G. Aspirin for vascular dementia [update]. Cochrane Database Syst Rev. 2000;(4):CD001296.
   Google Scholar
• Amarenco P, Bogousslavsky J, Callahan A 3rd, et al., for the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. Highdose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355(6):549–559.
   PubMed Web of Science ®Google Scholar
• Bernick C, Katz R, Smith NL, et al. Statins and cognitive function in the elderly: the Cardiovascular Health Study. Neurology. 2005;65(9):1388–1394.
   PubMed Web of Science ®Google Scholar
• Rea TD, Breitner JC, Psaty BM, et al. Statin use and the risk of incident dementia: the Cardiovascular Health Study. Arch Neurol. 2005;62(7):1047–1051.
   PubMed Web of Science ®Google Scholar
• Li G, Higdon R, Kukull WA, et al. Statin therapy and risk of dementia in the elderly: A community-based prospective cohort study. Neurology. 2004; 63(9):1624–1628.
   PubMed Web of Science ®Google Scholar
• Zandi PP. Sparks DL. Khachaturian AS. et al., for the Cache County Study Investigators. Do statins reduce risk of incident dementia and Alzheimer disease? Arch Gen Psychiatry. 2005;62(2):217–224.
   Google Scholar
• van Dongen MC, van Rossum E, Kessels AG, Sielhorst HJ, Knipschild PG. The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: new results of a randomized clinical trial. J Am Geriatr Soc 2000;48(10):1183–1194.
   PubMed Web of Science ®Google Scholar
• Black S, Romang C, Geldmacher DS, et al., Donepezil 307 Vascular Dementia Study Group. Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial. Stroke. 2003;34:2323–2330.
   PubMed Web of Science ®Google Scholar
• Wilkinson D, Doody R, Helme R, et al., Donepezil 308 Study Group. Donepezil in vascular dementia: a randomized, placebo-controlled study. Neurology. 2003;61:479–486.
   PubMed Web of Science ®Google Scholar
• Auchus AP, Brashear HR, Salloway S, et al., for the GAL-INT-26 Study Group. Galantamine treatment of vascular dementia: A randomized trial. Neurology. 2007;69(5): 448–458.
   PubMed Web of Science ®Google Scholar
• Malouf R, Birks J. Donepezil for vascular cognitive impairment. Cochrane Database of Syst Rev. 2004;(1):CD004395
   Google Scholar
• Craig D, Birks J. Rivastigmine for vascular cognitive impairment. Cochrane Database of Syst Rev. 2005;(2):CD004744.
   Google Scholar
• Craig D, Birks J. Galantamine for vascular cognitive impairment. Cochrane Database of Syst Rev. 2006;(1):CD004746.
   Google Scholar
• McShane R, Areosa Sastre A, Minakaran N. Memantine for dementia. Cochrane Database of Syst Rev. 2006;(2):CD003154.
   PubMedGoogle Scholar